GLP-1 Heart Benefits: Blood Pressure Matters, But So Does Weight
GLP-1 drugs cut major cardiovascular events. Ambulatory monitoring suggests blood pressure gets more credit—but weight and direct effects still matter.
GLP-1 Drugs for Teens With Obesity: What the Trials Show
Do GLP-1 drugs help teens with obesity? Pediatric trials show lower BMI and risk markers, but long-term safety, rebound, and growth data remain unknown.
Intermittent Fasting and Brain Fog: What Trials Actually Show
Intermittent fasting may improve weight and metabolic markers, but mental-clarity claims outrun human trials, while cognitive side effects remain unmeasured.
Semaglutide in Type 1 Diabetes: Why AID Changes the Math
Semaglutide improved weight and CGM outcomes in adults with type 1 diabetes, obesity, and automated insulin delivery, but remains off-label and unproven.
How Much Carb Should You Cut? The 30–40% Evidence Zone
How much carbohydrate should you cut for weight loss? Evidence from 110 RCTs points to a 30–40% energy range; deeper cuts offer less certain returns over time.